Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents

Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents

Late in-stent restenosis (ISR) has raised concerns regarding the long-term efficacy of drug-eluting stents (DES). The role of vascular endothelial growth factor (VEGF) in the pathological process of ISR is controversial. This retrospective study aimed to investigate the relationship between serum VE...

Full description

Bibliographic Details
Main Authors:	Jiasheng Yin, Li Shen, Meng Ji, Yizhe Wu, Sishi Cai, Jiahui Chen, Zhifeng Yao, Junbo Ge
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2017/8730271

Similar Items

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
by: Nisha Ohri, MD, et al.
Published: (2016-01-01)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
by: Violeta Dinesch, et al.
Published: (2017-04-01)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Published: (2017-04-01)

Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug- Eluting Stents
by: Negar Faramarzi, et al.
Published: (2015-10-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
by: Sohila Refahi, et al.
Published: (2019-03-01)

Risk assessment score for drug eluting stent restenosis
by: Z. A. Gabbasov, et al.
Published: (2018-09-01)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
by: Yen-Wen Liu, et al.
Published: (2021-09-01)

Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
by: Kakhaber Etsadashvili, et al.
Published: (2011-06-01)

Drug-eluting stents or balloon angioplasty for drug-eluting stent-associated restenosis: An observational follow-up study of first-time versus repeated restenosis
by: Mohamed Aboel-Kassem F. Abdelmegid, et al.
Published: (2017-04-01)

Role of eosinophil granulocytes in the occurrence of restenosis in patients after coronary stenting with drug-eluting stents
by: Z A Gabbasov, et al.
Published: (2014-09-01)

Long-Term Clinical Outcome after Sirolimus-Stent Implantation for in Sirolimus-Eluting Stent Restenosis
by: Alain Guidon, et al.
Published: (2008-01-01)

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
by: Ganesh Paramasivam, et al.
Published: (2019-11-01)

Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era
by: Omar A. Meelu, MS, et al.
Published: (2017-03-01)

Clinical characteristics of early and late drug-eluting stent in-stent restenosis and mid-term prognosis after repeated percutaneous coronary intervention
by: Jian-Feng Zheng, et al.
Published: (2020-11-01)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
by: Jorge A Arroyave C, et al.
Published: (2012-06-01)

In-stent restenosis of drug-eluting stents in patients with diabetes mellitus: Clinical presentation, angiographic features, and outcomes
by: Ganesh Paramasivam, et al.
Published: (2019-12-01)

The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
by: Chengbin Zheng, et al.
Published: (2019-01-01)

The Role Of Inflammation In Stent Restenosis More Than 1 Year Afetr Drug Eluting Stent Implantation
by: Hasan Shemirani, et al.
Published: (2011-09-01)

In-Stent Restenosis
by: Anna Lena Lahmann, MD, et al.
Published: (2020-01-01)

Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis
by: Kong-Yong Cui, et al.
Published: (2018-01-01)

Inflammation and in-stent restenosis: the role of serum markers and stent characteristics in carotid artery stenting.
by: Katrin Wasser, et al.
Published: (2011-01-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
by: Yi-Xing Yang, et al.
Published: (2020-01-01)

Impact of the distance from the stent edge to the residual plaque on edge restenosis following everolimus-eluting stent implantation.
by: Masao Takahashi, et al.
Published: (2015-01-01)

Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate
by: Dauer Cheryl, et al.
Published: (2005-12-01)

Impact of Paclitaxel-Eluting Balloons Compared to Second-Generation Drug-Eluting Stents for of In-Stent Restenosis in a Primarily Acute Coronary Syndrome Population
by: Guillaume Marquis-Gravel, et al.
Published: (2017-09-01)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
by: Jing Wang, et al.
Published: (2021-12-01)

Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis
by: Sheng -yuan Chen, et al.
Published: (2017)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Aslı Tanındı, et al.
Published: (2015-07-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Murat Gençbay
Published: (2015-07-01)

The association between epicardial fat thickness in echocardiography and coronary restenosis in drug eluting stents
by: Fariborz Nikaeen, et al.
Published: (2011-04-01)

Trombose coronariana tardia secundária a implante de stent com paclitaxel sem reestenose dos stents convencionais Late coronary thrombosis secondary to implantation of paclitaxel-eluting stent without restenosis of conventional stents
by: Luciano Maurício de Abreu, et al.
Published: (2007-05-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

Drug-Eluting Balloons versus Second-Generation Drug-Eluting Stents for Treating In-Stent Restenosis in Coronary Heart Disease after PCI: A Meta-Analysis
by: Wen-Juan Xiu, et al.
Published: (2018-01-01)

Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent
by: Zsolt Bagyura, et al.
Published: (2017-01-01)

Effect of pioglitazone on in-stent restenosis after coronary drug-eluting stent implantation: a meta-analysis of randomized controlled trials.
by: Ming-duo Zhang, et al.
Published: (2014-01-01)

The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting
by: Hajizadeh Reza, et al.
Published: (2017-12-01)

Gene Delivery from Stents for Prevention of In Stent Restenosis
by: Ilia Fishbein, et al.
Published: (2016-12-01)

In Stent Restenosis Predictors after Carotid Artery Stenting
by: Mirco Cosottini, et al.
Published: (2010-01-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent Implantation
by: Zheng Qin, et al.
Published: (2017-01-01)